- Title
- MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
- Creator
- Talseth-Palmer, Bente A.; McPhillips, Mary; Groombridge, Claire; Spigelman, Allan; Scott, Rodney J.
- Relation
- Hereditary Cancer in Clinical Practice Vol. 8
- Publisher Link
- http://dx.doi.org/10.1186/1897-4287-8-5
- Publisher
- BioMed Central
- Resource Type
- journal article
- Date
- 2010
- Description
- Background: Approximately 10% of Lynch syndrome families have a mutation in MSH6 and fewer families have a mutation in PMS2. It is assumed that the cancer incidence is the same in families with mutations in MSH6 as in families with mutations in MLH1/MSH2 but that the disease tends to occur later in life, little is known about families with PMS2 mutations. This study reports on our findings on mutation type, cancer risk and age of diagnosis in MSH6 and PMS2 families. Methods: A total of 78 participants (from 29 families) with a mutation in MSH6 and 7 participants (from 6 families) with a mutation in PMS2 were included in the current study. A database of de-identified patient information was analysed to extract all relevant information such as mutation type, cancer incidence, age of diagnosis and cancer type in this Lynch syndrome cohort. Cumulative lifetime risk was calculated utilising Kaplan-Meier survival analysis. Results: MSH6 and PMS2 mutations represent 10.3% and 1.9%, respectively, of the pathogenic mutations in our Australian Lynch syndrome families. We identified 26 different MSH6 and 4 different PMS2 mutations in the 35 families studied. We report 15 novel MSH6 and 1 novel PMS2 mutations. The estimated cumulative risk of CRC at age 70 years was 61% (similar in males and females) and 65% for endometrial cancer in MSH6 mutation carriers. The risk of developing CRC is different between males and females at age 50 years, which is 34% for males and 21% for females. Conclusion: Novel MSH6 and PMS2 mutations are being reported and submitted to the current databases for identified Lynch syndrome mutations. Our data provides additional information to add to the genotype-phenotype spectrum for both MSH6 and PMS2 mutations.
- Subject
- Lynch syndrome; mutations; cancer risk; cancer diagnosis
- Identifier
- http://hdl.handle.net/1959.13/928590
- Identifier
- uon:10386
- Identifier
- ISSN:1731-2302
- Language
- eng
- Full Text
- Reviewed
- Hits: 14454
- Visitors: 3702
- Downloads: 405
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT01 | Publisher version (open access) | 516 KB | Adobe Acrobat PDF | View Details Download |